Literature DB >> 20938644

Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis.

Paul F Engelhardt1, Nike Morakis, Lukas K Daha, Britta Esterbauer, Claus R Riedl.   

Abstract

INTRODUCTION AND HYPOTHESIS: While the short-term efficacy of intravesical hyaluronan for bladder pain syndrome/interstitial cystitis (BPS/IC) has been demonstrated, no data exist on the long-term outcome of this therapy.
METHODS: Seventy BPS/IC patients treated with intravesical hyaluronan therapy from 2001 to 2003 were asked to rate their present status of bladder symptoms on a visual analog scale.
RESULTS: Forty-eight of 70 patients responded after a mean follow-up of 4.9 years. The average initial VAS score of 8.15 had been reduced to 2.71 after therapy and further to 2.14 5 years later. Fifty percent of patients (24/48) reported complete bladder symptom remission at 5 years follow-up without any additional therapy; 41.7% (20/48) with symptom recurrence was improved with hyaluronan maintenance therapy. No improvement was reported by four patients.
CONCLUSIONS: Besides a high rate of acute symptom remission, intravesical hyaluronan also shows long-term efficacy in a considerable number of BPS/IC patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938644     DOI: 10.1007/s00192-010-1294-y

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  18 in total

1.  Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid.

Authors:  D Porru; G Campus; D Tudino; E Valdes; A Vespa; R M Scarpa; E Usai
Journal:  Urol Int       Date:  1997       Impact factor: 2.089

2.  Effect of pentosan polysulfate therapy on intravesical potassium sensitivity.

Authors:  C Lowell Parsons; John Forrest; J Curtis Nickel; Robert Evans; L Keith Lloyd; Jack Barkin; Phillip G Mosbaugh; David M Kaufman; Jose M Hernandez-Graulau; Linda Atkinson; Detlef Albrecht
Journal:  Urology       Date:  2002-03       Impact factor: 2.649

Review 3.  Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review.

Authors:  Benedikte Richter Toft; Jørgen Nordling
Journal:  Curr Opin Urol       Date:  2006-07       Impact factor: 2.309

4.  A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis.

Authors:  J J Bade; M Laseur; A Nieuwenburg; L T van der Weele; H J Mensink
Journal:  Br J Urol       Date:  1997-02

5.  Potassium leak test predicts outcome in interstitial cystitis.

Authors:  J M Teichman; B J Nielsen-Omeis
Journal:  J Urol       Date:  1999-06       Impact factor: 7.450

6.  The potassium sensitivity test: a predictor of treatment response in interstitial cystitis.

Authors:  Suresh K Gupta; Lol Pidcock; Nigel J Parr
Journal:  BJU Int       Date:  2005-11       Impact factor: 5.588

7.  Effect of intravesical glycosaminoglycan substitution therapy on bladder pain syndrome/interstitial cystitis, bladder capacity and potassium sensitivity.

Authors:  Lukas K Daha; Claus R Riedl; Dara Lazar; Reiner Simak; Heinz Pflüger
Journal:  Scand J Urol Nephrol       Date:  2008

8.  Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis.

Authors:  A Morales; L Emerson; J C Nickel; M Lundie
Journal:  J Urol       Date:  1996-07       Impact factor: 7.450

Review 9.  Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract.

Authors:  R E Hurst
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

10.  A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis.

Authors:  J Curtis Nickel; Blair Egerdie; Joe Downey; Rajiva Singh; Anthony Skehan; Leslie Carr; Karen Irvine-Bird
Journal:  BJU Int       Date:  2008-09-03       Impact factor: 5.588

View more
  30 in total

Review 1.  Interstitial cystitis/bladder pain syndrome: diagnosis and management.

Authors:  I Offiah; S B McMahon; B A O'Reilly
Journal:  Int Urogynecol J       Date:  2013-02-22       Impact factor: 2.894

2.  Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome.

Authors:  Yik N Lim; Peter Dwyer; Christine Murray; Debjyoti Karmakar; Anna Rosamilia; Elizabeth Thomas
Journal:  Int Urogynecol J       Date:  2016-12-16       Impact factor: 2.894

3.  Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study.

Authors:  Davide De Vita; Salvatore Giordano
Journal:  Int Urogynecol J       Date:  2012-05-22       Impact factor: 2.894

4.  Safety and efficacy of Intravesical hyaluronic acid/chondroitin sulfate in the treatment of refractory painful bladder syndrome.

Authors:  Hammouda Sherif; Ahmed Sebay; Wael Kandeel; Tarek Othman; Abdallah Fathi; Ahmed Mohey; Ali Eshazly
Journal:  Turk J Urol       Date:  2018-11-21

5.  Clinical comparision of intravesical hyaluronic acid and hyaluronic acid-chondroitin sulphate therapy for patients with bladder pain syndrome/interstitital cystitis.

Authors:  Omer Gülpınar; Aytaç Kayış; Evren Süer; Mehmet İlker Gökçe; Adil Güçal Güçlü; Nihat Arıkan
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

6.  [The care situation of patients with interstitial cystitis in Germany: results of a survey of 270 patients].

Authors:  D Jocham; G Froehlich; F Sandig; A Ziegler
Journal:  Urologe A       Date:  2013-05       Impact factor: 0.639

7.  Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: a meta-analysis.

Authors:  Davide De Vita; Henrik Antell; Salvatore Giordano
Journal:  Int Urogynecol J       Date:  2012-11-06       Impact factor: 2.894

8.  Treatment costs of bladder pain syndrome/interstitial cystitis in Austria: a pharmacoeconomic approach following current guidelines.

Authors:  Claus Riedl; Paul Engelhardt; Bernhard Schwarz
Journal:  Clin Drug Investig       Date:  2013-10       Impact factor: 2.859

Review 9.  Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence.

Authors:  Massimo Lazzeri; Rodolfo Hurle; Paolo Casale; NicolòMaria Buffi; Giovanni Lughezzani; Girolamo Fiorini; Roberto Peschechera; Luisa Pasini; Silvia Zandegiacomo; Alessio Benetti; Gianluigi Taverna; Giorgio Guazzoni; Guido Barbagli
Journal:  Ther Adv Urol       Date:  2015-12-16

10.  Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome/interstitial cystitis: long-term treatment results.

Authors:  M Cervigni; F Natale; L Nasta; A Mako
Journal:  Int Urogynecol J       Date:  2012-05-09       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.